Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
Open accessThe DOI matches its Crossref record; 196 of the 197 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To assess the accuracy in diagnosing heart failure of clinical features and potential primary care investigations, and to perform a decision analysis to test the impact of plausible diagnostic strategies on costs and diagnostic yield in the UK health-care setting. DATA SOURCES: MEDLINE and CINAHL were searched from inception to 7 July 2006. 'Grey literature' databases and conference proceedings were searched and authors of relevant studies contacted for data that could not be extracted from the published papers. REVIEW METHODS: A systematic review of the clinical evidence was carried out according to standard methods. Individual patient data (IPD) analysis was performed on nine studies, and a logistic regression model to predict heart failure was developed on one of the data sets and validated on the other data sets. Cost-effectiveness modelling was based on a decision tree that compared different plausible investigation strategies. RESULTS: Dyspnoea was the only symptom or sign with high sensitivity (89%), but it had poor specificity (51%). Clinical features with relatively high specificity included history of myocardial infarction (89%), orthopnoea (89%), oedema (72%), elevated jugular venous pressure (70%), cardiomegaly (85%), added heart sounds (99%), lung crepitations (81%) and hepatomegaly (97%). However, the sensitivity of these features was low, ranging from 11% (added heart sounds) to 53% (oedema). Electrocardiography (ECG), B-type natriuretic peptides (BNP) and N-terminal pro-B-type natriuretic peptides (NT-proBNP) all had high sensitivities (89%, 93% and 93% respectively). Chest X-ray was moderately specific (76-83%) but insensitive (67-68%). BNP was more accurate than ECG, with a relative diagnostic odds ratio of ECG/BNP of 0.32 (95% CI 0.12-0.87). There was no difference between the diagnostic accuracy of BNP and NT-proBNP. A model based upon simple clinical features and BNP derived from one data set was found to have good validity when applied to other data sets. A model substituting ECG for BNP was less predictive. From this a simple clinical rule was developed: in a patient presenting with symptoms such as breathlessness in whom heart failure is suspected, refer directly to echocardiography if the patient has a history of myocardial infarction or basal crepitations or is a male with ankle oedema; otherwise, carry out a BNP test and refer for echocardiography depending on the results of the test. On the basis of the cost-effectiveness analysis carried out, such a decision rule is likely to be considered cost-effective to the NHS in terms of cost per additional case detected. The cost-effectiveness analysis further suggested that, if likely benefit to the patient in terms of improved life expectancy is taken into account, the optimum strategy would be to refer all patients with symptoms suggestive of heart failure directly for echocardiography. CONCLUSIONS: The analysis suggests the need for important changes to the NICE recommendations. First, BNP (or NT-proBNP) should be recommended over ECG and, second, some patients should be referred straight for echocardiography without undergoing any preliminary investigation. Future work should include evaluation of the clinical rule described above in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, dapagliflozin reduced all-cause mortality (HR 0.83; 95% CI, 0.71-0.97)and improved symptoms, physical function, and quality of life in patients with HFrEF.491,492”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [491]
Experimental — accuracy not yet measuredIn the citing paper
“Therapy with dapagliflozin 10 mg o.d. vs. placebo reduced the risk of the primary outcome, a composite of worsening HF (hospitalization or an urgent visit resulting in i.v.therapy for HF) or CV death, by 26% (HR 0.74; 95% CI, 0.65-0.85).”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [491]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
Maisel, A. S., Krishnaswamy, P., Nowak, R. M., McCord, J., Hollander, J. E., Duc, P., Omland, T., Storrow, A. B., Abraham, W. T., Wu, A. H. B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020233 · Cited by 3,362
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
Research works printed but not linked: 2
- AJ. Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? Int J Cardiol 1997;62:31–6.
- X-ray, radionuclide ventriculography and right heart catheterization. Eur Heart J 1989;10:1017–28.
Cited by
Items 401–500 of 510
Low LDL Levels are Associated with the Absence of Dyspnea in Patients with Chronic Heart Failure
Богданова, Т. М., Gorbunova, L. A., Goryachev, V. S., & Fedonnikov, A. (2025) · Russian Open Medical Journal · doi:10.15275/rusomj.2025.0413 · Cited by 1
Alexescu, T., Somesfalean, M.-I., Perné, M.-G., Gerdanovics, C.-A., Para, I., Milaciu, M. V., Cozma, A., & Gherman-Lencu, C.-C. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062376 · Cited by 1
“It is characterized by a clinical syndrome comprising symptoms such as dyspnea, asthenia, and fatigue, as well as objective signs including peripheral edema, pulmonary crackles, elevated jugular venous pressure, and hepatomegaly [3,4].”
Boyle, R., & Patel, N. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72717 · Cited by 1
Ślot, M., Zasada, I., Olejniczak, W., Sakowicz, A., & Bielecka-Dabrowa, A. M. (2026) · Scientific Reports · doi:10.1038/s41598-026-60247-w · Cited by 1
Krüger, W. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-54973-6_2 · Cited by 1
Why should you care about academic general practice?
Mughal, F. (2012) · BMJ · doi:10.1136/bmj.e3293 · Cited by 1
Semiología y diagnóstico diferencial de la insuficiencia cardíaca crónica
Giraldo, H. J. U., Jiménez-Salazar, S., Buitrago-Toro, K., & Bolaños, M. E. (2018) · Revista Médica de Risaralda · doi:10.22517/25395203.16181 · Cited by 3
Dixon, S. (2019) · Healthcare Management Forum · doi:10.1177/0840470419843552 · Cited by 1
“The analysis used the NICE analysis of natriuretic peptide testing for suspected heart failure, with a 5% improvement in absolute uptake for a national cost of £28,186.(14) Based on a cost-effectiveness threshold of £20,000 per QALY gained, the modeled activity had a value of £15,915,094 over a 10-year period.”
MethodKhalifa, M. M. M., Said, A., Mortada, A., & Shehata, H. (2020) · Journal of Cardiovascular Echography · doi:10.4103/jcecho.jcecho_66_19 · Cited by 1
“QRS prolongation is an independed stable criteria used for long time for selection of patients for CRT insertion, an inverse correlation exists between QRS prolongation measured by surface ECG and left ventricular ejection fraction (LVEF),[2] Barold et al.”
BackgroundMethodNecesitamos disponer de BNP urgente
Casademont, J. (2011) · Emergencias · Cited by 1
Natriureticus peptidek mérése szívelégtelen betegekben: a helyes laboratóriumi és klinikai gyakorlat
Kovács, L., Nyolczas, N., Habon, T., Sepp, R., Piróth, Z., Hajas, Á., Boncz, I., Tomcsányi, J., Kappelmayer, J., & Merkely, B. P. (2015) · Orvosi Hetilap · doi:10.1556/650.2015.30219 · Cited by 1
“A natriureticus peptidek mérése javasolható a szívelégtelenség kizárására dyspnoés betegek esetén (IIa C szintű evidencia) [12].”
We are asking more questions about NICE appraisal of Tamiflu
Rawlins, M. D. (2012) · BMJ · doi:10.1136/bmj.e8420 · Cited by 1
Cabré, J. J., Ripoll, M., Hernández, J. M., Basora, J., Bejarano‐Romero, F., & Arija, V. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-430 · Cited by 2
Spencer, A., Brabin, L., Roberts, S. A., Patnick, J., Elton, P., & Verma, A. (2015) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2015-101283 · Cited by 1
Giumelli, C., Reverzani, A., Volpi, R., & Chesi, G. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.2015.550 · Cited by 1
Acute and Chronic Heart Failure
Brooks, A. C., & Vidula, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-89725-7_13 · Cited by 1
Do oral steroids improve hearing outcomes in children with otitis media with effusion?
Hughes, A., & Khong, T. K. (2019) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2019.000068 · Cited by 1
Congestion in acute heart failure trials and registries: a systematic review
Ahmad, F. (2020) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.80247 · Cited by 1
Sukthomya, S., 江原, 義., Srisawasdi, G., Suwannakin, A., & 勝平, 純. (2020) · Institutional Repositories DataBase (IRDB) · Cited by 2
Herzinsuffizienz: Diagnostik und Therapie gemäß der ESC Leitlinie 2021
Herting, J., Fischer, T. H., & Maack, C. (2022) · Der Nephrologe · doi:10.1007/s11560-022-00575-w · Cited by 2
Bejarano, J. M. L., Domingo, M., González, A. M., Verdú-Rotellar, J. M., Rodríguez, Á. C., & Robleda, L. E. (2014) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(14)70875-8 · Cited by 3
Little, P. S., Becque, T., Hay, A. D., Francis, N. A., Stuart, B. L., O’Reilly, G., Thompson, N., Hood, K., Moore, M. V., & Verheij, T. J. (2022) · British Journal of General Practice · doi:10.3399/bjgp.2022.0239 · Cited by 1
Kuwahata, S., Ushikai, J., Yamakawa, N., Inaba, M., Kusumoto, K., Kamekou, M., Saihara, K., Takenaka, T., Murata, N., Kato, T., et al. (2022) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2022.11.002 · Cited by 1
Ahmad, W. A. W., Ghazi, A. M., Ghapar, A. K. A., Muthusamy, T. S., Liew, H. B., Abidin, I. Z., Ong, M. L., Ross, N. T., Cham, Y. L., Ho, W. S., et al. (2023) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2023.30.1.5 · Cited by 1
Abola, M. T. B., Punzalan, F. E. R., Magno, J. D. A., Oliva, R., Cabanag-Demerre, E. P., Estrada–Yamamoto, M., Gabriel, E. A., Sibulo, A. S., Limpin, M. E., & Vilela, G. C. (2025) · Philippine journal of cardiology. · doi:10.69944/pjc.459701570a · Cited by 1
Transcript Level Analysis Improves the Understanding of Bladder Cancer
Ao, X., & Li, S. C. (2020) · doi:10.5121/csit.2020.100503 · Cited by 1
Are glucosamine and chondroitin natural remedies for osteoarthritis?
Train, A. D., Moe, S., & Allan, G. M. (2021) · Canadian Family Physician · doi:10.46747/cfp.6702111 · Cited by 1
Natriuretic peptide tests in suspected acute heart failure
Rutten, F. H., & Hoes, A. W. (2015) · BMJ · doi:10.1136/bmj.h1164 · Cited by 2
Delivering quality and value in heart failure
Hobbs, R. F. (2009) · BMJ · doi:10.1136/bmj.b1672 · Cited by 1
Optimisation of Pacemaker Therapy for Cardiac Function
Gierula, J. (2017) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Unveiling the gap of heart failure: a DATASUS studyPreprint
Batista, V. C., Vitorasso, R. L., Pileggi, V. N., Picoli, R. M., & Bilevicius, E. (2024) · medRxiv · doi:10.1101/2024.06.16.24308996 · Cited by 1
“Additionally, healthcare providers may encounter difficulties in interpreting diagnostic tests accurately, especially in cases where imaging and biomarkers yield inconclusive results or where comorbid conditions complicate the diagnostic process(14,15).”
BackgroundRinaldi, P. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Barber, K., Deaton, C., McCann, G. P., Bernhardt, L., Prinjha, S., Kalajahi, R. A., Ali, M. R., Squire, I. B., Taylor, C. J., Cleland, J. G. F., et al. (2026) · medRxiv · doi:10.64898/2026.01.23.26344713 · Cited by 1
Latent models in the development and improvement of tools for health outcomes measurement
Silva, M. S. B. D. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/2rhr-5v27
Vaes, B. (2012) · DIAL (Catholic University of Leuven)
The prediction of adverse outcomes following major non-cardiac surgery
Payne, C. J. (2013) · Enlighten: Theses (The University of Glasgow)
Chronic Heart failure – Therapeutic Approaches.
Šikić, J. (2015) · Cardiologia Croatica · doi:10.15836/ccar.2015.46
NICE Guideline for Management of Chronic Heart Failure in Adults
Mant, J., Al‐Mohammad, A., & Swain, S. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-1-201201030-00025
Self-citationVirtual technology can serve to assist diagnosis
Sharma, N. (2013) · British Journal of Hospital Medicine · doi:10.12968/hmed.2013.74.8.475a
Accesibilidad del médico de atención primaria a la tecnología de diagnóstico
Granell, J. (2012) · Atención Primaria · doi:10.1016/j.aprim.2012.02.002
Anomalies in criteria for heart failure with preserved ejection fraction
Al‐Mohammad, A. (2013) · British Journal of Hospital Medicine · doi:10.12968/hmed.2013.74.6.355a
A 45-Year-Old Male with New Onset Shortness of Breath
Ralph, K., Dmytriw, A. A., & Miller, R. (2015) · Dalhousie Medical Journal · doi:10.15273/dmj.vol41no2.5948
The detection of left ventricular hypertrophy and diastolic dysfunction
Norton, G. (2012) · South African Family Practice · doi:10.1080/20786204.2012.10874207
Clinical usefulness of B-type natriuretic peptide in cardiac rehabilitation and heart failure
Leslie, R. (2010) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2010.5.10.78862
Clinical benefits of integrating cardiac and vascular models
Graf, I. M., Miri, R., Smalling, R. W., & Emelianov, S. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.616195
Vallabhajosyula, S., DeSimone, D. C., & Anavekar, N. S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.019
Heart failure : biomarker effect and influence on quality of life
Karlström, P. (2016) · Linköping University medical dissertations · doi:10.3384/diss.diva-124560
“The signs and symptoms are not specific to HF and the diagnosis can therefore be difficult especially in early stages [53, 54].”
BackgroundThe clinical pathway of patients with heart failure in primary care
Taylor, C. J. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
What about physical activity and exercise medicine?
Weiler, R., Adlan, M., Drodge, A., & Premawardhana, L. (2010) · Clinical Medicine · doi:10.7861/clinmedicine.10-5-522
ISCHAEMIC HEART DISEASE – SURGICAL TREATMENT AND POST-OPERATIVE COMPLICATIONS
Haxhibeqiri‐Karabdic, I., Kabil, E., & Vranić, H. (2015) · doi:10.5644/pi2015-158-07
“It is concluded that 63% (30) of patients who were surgically treated have a survival rate of 5 years.”
BackgroundChetram, V. (2016) · UWSpace (University of Waterloo)
Aspects of treatment and care of nursing home residents. Challenges and possibilities.
Bolmsjö, B. B. (2016) · Lund University Publications (Lund University)
Decaluwe, K., Degryse, J., & Vaes, B. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0481-4
“could also be applied in patients aged 75 years old and older [10, 11].”
MethodThacker, V., & Trivedi, J. (2016) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20163745
Neue Herzinsuffizienz-Guidelines: Update für die Praxis
Rickenbacher, P. R. (2017) · Praxis · doi:10.1024/1661-8157/a002622
Mir, N.-U. R., Asghar, N., & Javed, S. (2017) · The Professional Medical Journal · doi:10.29309/tpmj/2017.24.06.1198
(2012) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(12)70419-x
Jakovljević, D. G. (2017) · Fizicka kultura · doi:10.5937/fizkul1702075j
Etude cellulaire et moléculaire de l'insuffisance cardiaque à fonction systolique préservée
Rouhana, S. (2018) · theses.fr (ABES) · doi:10.70675/b892998ez37efz4707zaf57zaf25ba754fd7 · Cited by 1
Freixa‐Pamias, R., González, A. M., Andrea, R., Gràcia, P. B., Iglesias, M. P., Mirabet, S., Crespo, M. C., Eizagaechevarría, N. M., Cuixart, C. B., Vázquez, J. A. Q., et al. (2019) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2018.12.004
Fabricius‐Bjerre, A. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.15.002639
Mining development knowledge to understand and support software logging practices
Li, H. (2018) · PolyPublie (École Polytechnique de Montréal)
Acoustic and afterload evaluation of left ventricular assist devices
Sundbom, P. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-161902
“The symptoms of HF are often non-specific, hence the clinical diagnosis might be hard.(51) In patients with obesity or pulmonary disease, the symptoms might be even harder to detect.”
BackgroundClinical characteristics and prognosis of patients with angina pectoris and heart failure
Badar, A. (2019) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.75073 · Cited by 1
La glucosamine et la chondroïtine sont-elles des remèdes naturels pour l’arthrose?
Train, A. D., Moe, S., & Allan, G. M. (2021) · Canadian Family Physician · doi:10.46747/cfp.6702e59
Surgical Ventricular Remodeling (SVR): Anesthesia Considerations
Giunta, L., Katz, D. J., & Leong, R. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-64739-1_25
Habedank, D., & Opitz, C. F. (2012) · Der Pneumologe · doi:10.1007/s10405-011-0567-6
Heart failure with reduced ejection fraction
Trinh, K., Campos, A., & Sharma, R. (2022) · Radiopaedia.org · doi:10.53347/rid-99423
Heart Failure Management for the Inpatient Provider
Gupta, T., Venkataraman, V., & DENGLE, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-95164-1_4
Deeb, M. A., Barbic, S. P., Featherstone, R. M., Dankoff, J., & Barbic, D. (2015) · Academic Emergency Medicine · doi:10.1111/acem.12583
Harris, K. R., & Thompson, M. K. (2012) · InnovAiT Education and inspiration for general practice · doi:10.1093/innovait/ins181
Herzinsuffizienz: Diagnostik und Therapie gemäß der ESC Leitlinie 2021
Herting, J., Fischer, T. H., & Maack, C. (2022) · Die Kardiologie · doi:10.1007/s12181-022-00569-x
Herzinsuffizienz: Diagnostik und Therapie gemäß der ESC Leitlinie 2021
Herting, J., Fischer, T. H., & Maack, C. (2022) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-022-00544-4
Insuficiencia Cardiaca Aguda Asociada a Pancreatitis Aguda: Reporte de Caso
Guaraca, C. A. L., Freire, E. B. O., Espinoza, O. E. M., Vásquez, M. C. Á., & Sarmiento, P. M. G. (2023) · Tesla Revista Científica · doi:10.55204/trc.v3i1.e161
“En un cierto porcentaje de pacientes, un episodio de ICA puede ser la primera presentación de una insuficiencia cardiaca, como en el caso de nuestra paciente, que no presentaba un diagnóstico previo, pero se asociaba a importantes comorbilidades (13).”
BackgroundRadiological microcirculatory findings in a relatively normal radiological picture of the lungs
Amosov, V. I., & Zolotnitskaya, V. P. (2023) · Regional blood circulation and microcirculation · doi:10.24884/1682-6655-2023-22-1-5-15
Najjarzadeh, M., Mohammad‐Alizadeh‐Charandabi, S., Jafarabadi, M. A., Abbasalizadeh, S., & Mirghafourvand, M. (2023) · Journal of Nursing Measurement · doi:10.1891/jnm-2022-0054
Intensivtherapie bei akuter Herzinsuffizienz, kardiogenem Schock und Herzbeuteltamponade
Iken, S., Calineata, M., Reyher, C., & Zierer, A. F. (2023) · Springer Reference Medizin · doi:10.1007/978-3-642-54675-4_61-2
Messias, I. F. (2023) · Revista Científica Multidisciplinar Núcleo do Conhecimento · doi:10.32749/nucleodoconhecimento.com.br/saude/ventriculo-esquerdo
Acceptability and feasibility of maternal screening for Group B Streptococcus: a rapid reviewPreprint
Constantinou, G., Webb, R., Ayers, S., Mitchell, E. J., & DANIELS, J. P. (2024) · medRxiv · doi:10.1101/2024.06.28.24309381
Ramzy, D. (2024) · Springer eBooks · doi:10.1007/978-3-030-86172-8_5-1
Intensivtherapie bei akuter Herzinsuffizienz, kardiogenem Schock und Herzbeuteltamponade
Iken, S., Calineata, M., Reyher, C., & Zierer, A. F. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-68699-7_61
Singhal, A. (2016) · Wiley eBooks · doi:10.1002/9781394321872.ch11
Charman, S. J., Anjani, J. V., Henderson, E. E., Vougas, K. N., Stefanetti, R. J., Blain, A. P., Okwose, N. C., Bailey, K. M., Seferovic, P. M., Mant, J., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5111208
Self-citationMorvai-Illés, B. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12194
Klinisch redeneren: diagnostiek van hartfalen bij COPD-patiënt in de eerste lijn
Oorschot, V. V., & Vaes, B. (2025) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.81.24.158
del Campo, R. R. (2022) · Actualización en Medicina de Familia · doi:10.55783/amf.181009
Sawalha, K., Rana, A., Alamat, L., Fancher, A. J., Albadaineh, M., López‐Candales, A., & Asif, T. (2025) · Cureus · doi:10.7759/cureus.94159
“Due to its heterogeneous nature of presentation and non-specific symptoms, a high index of suspicion is required to trigger appropriate testing in a timely fashion [8,9].”
Diagnosis of heart failure in primary care: missed opportunities
Mant, J., & Okwose, N. C. (2025) · The Lancet Primary Care · doi:10.1016/j.lanprc.2025.100066
Self-citationKılıç, M. E., Arayıcı, M. E., Akbilgiç, O., & Yılmaz, M. B. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.12.022 · Cited by 1
Jones, A. (2020) · Loughborough University Research Repository (Loughborough University) · doi:10.26174/thesis.lboro.12555143
Sydämen systolisen vajaatoiminnan lääkehoidon toteutuminen Tyks Sydänkeskuksessa vuosina 2020–2022
Saxberg, J. (2024) · UTUPub (University of Turku)
When the heart can't take it anymore : peoples' experiences of living with heart failure
Franzén, A., & Sylwan, E. (2023) · Sophiahemmet University Library (Sophiahemmet University)
Demmer, J. J. (2025) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00037521
Miranda, D. J. C., & Torres, A. A. C. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20254399
Cubillo, Á. C. M., & Sánchez, C. G. (2026) · Actualización en Medicina de Familia · doi:10.55783/amf.220103
Cardiovascular Disease: Part E
Kaufman, V. (2026) · Springer eBooks · doi:10.1007/978-3-031-90919-1_47-1
Agrinier, N. (2013) · theses.fr (ABES) · doi:10.70675/e4c15be2z8979z4297za8ffzdd26ec29f69f · Cited by 2
Metadata
- Authors
- Mant, J., Doust, J., Roalfe, A., Barton, P., Cowie, M., Glasziou, P., Mant, D., McManus, R., Holder, R., Deeks, J., Fletcher, K., Qume, M., Sohanpal, S., Sanders, S., & Hobbs, F.
- Affiliations
- University of Birmingham (GB)
- Bond University (AU)
- National Institutes of Health (US)
- University of Oxford (GB)
- Corresponding author
- Mant, J
- Venue
- Health Technology Assessment
- Published
- 2009-07
- Volume
- 13
- Issue
- 32
- Pages
- 1-207, iii
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2075669100
- Cited by
- 498
- References
- 197
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 18 · 2023: 34 · 2022: 26 · 2021: 29 · 2020: 32 · 2019: 34 · 2018: 28 · 2017: 35 · 2016: 41 · 2015: 36 · 2014: 36 · 2013: 31 · 2012: 38
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Health Technology Assessment (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Bond University Research Portal (Bond University) (submittedVersion, other-oa)
- e-publications@bond (Bond University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Health Technology Assessment programme (05/06/01)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart failure diagnosis, diagnostic accuracy, dyspnea, brain natriuretic peptide, NT-proBNP, electrocardiogram, chest radiography, clinical prediction rules, cost-effectiveness, diagnostic approach, primary care, echocardiography, decision analysis, sensitivity and specificity, clinical features, edema, orthopnea, hepatomegaly
- MeSH terms
- Aged, Aged, 80 and over, Diagnosis, Differential, Female, Heart Failure, Heart Function Tests, Humans, Male, Middle Aged, Primary Health Care, State Medicine, Practice Guidelines as Topic, Natriuretic Peptide, Brain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.